Vistagen Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:VTGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -18.85 M-13.76 M-17.63 M-16.2 M-14.71 M -62.3 M Cash from investing activities -788 K-94 K104 K-99 K0 -89 K Cash from financing activities 1.49 M27.65 M2.11 M-283 K909 K 30.39 M Free cash flow -18.85 M-13.82 M-17.66 M-16.2 M-14.71 M -62.38 M

News

Vistagen Therapeutics, Inc. (VTGN) Discusses PALISADE-4 Phase III Results and Post-Hoc Analyses in Social Anxiety Disorder Transcript

Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates

HealthEquity (HQY) Q1 Earnings and Revenues Top Estimates

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates

Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates

Vistagen Therapeutics reduces workforce by 20 percent to manage costs

VistaGen at TD Cowen Conference: Pherine Platform in Focus

Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript

Earnings call transcript: VistaGen Therapeutics Q3 2026 highlights AI-driven trial analysis

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates

Vistagen Therapeutics reports Phase 3 trial for fasedienol did not meet endpoint

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%